JEWISH KING JESUS IS COMING AT THE RAPTURE FOR US IN THE CLOUDS-DON'T MISS IT FOR THE WORLD.THE BIBLE TAKEN LITERALLY- WHEN THE PLAIN SENSE MAKES GOOD SENSE-SEEK NO OTHER SENSE-LEST YOU END UP IN NONSENSE.GET SAVED NOW- CALL ON JESUS TODAY.THE ONLY SAVIOR OF THE WHOLE EARTH - NO OTHER. 1 COR 15:23-JESUS THE FIRST FRUITS-CHRISTIANS RAPTURED TO JESUS-FIRST FRUITS OF THE SPIRIT-23 But every man in his own order: Christ the firstfruits; afterward they that are Christ’s at his coming.ROMANS 8:23 And not only they, but ourselves also, which have the firstfruits of the Spirit, even we ourselves groan within ourselves, waiting for the adoption, to wit, the redemption of our body.(THE PRE-TRIB RAPTURE)
REVELATION VERESE BY VERSE BY DR JACK AND REXELLA VAN IMPE
https://www.youtube.com/watch?v=RIYtJAUUx0o&list=PLQ6QjtBzr5_eln4Wwdyqw8niA97w7bpv6
TAPE 1 - REV CH 1 - 4:6
https://www.youtube.com/watch?v=4egxDQbC-Po&list=PLQ6QjtBzr5_eln4Wwdyqw8niA97w7bpv6&ind
TAPE 2 - REV CH 4:7-8 TO 9:31
https://www.youtube.com/watch?v=iAHF8qRW_0c&list=PLQ6QjtBzr5_eln4Wwdyqw8niA97w7bpv6&index=3
TAPE 3 - REV CH 10:1 TO 14:1
https://www.youtube.com/watch?v=J8nvow7gDsI
TAPE 4 - REV CH 14:2 TO REV 18:25
https://www.youtube.com/watch?v=2jzejO8qr1g
TAPE 5 - REV CH 19:1 TO REV 22:20
https://www.youtube.com/watch?v=ZFSaL7wuOZU&list=PLQ6QjtBzr5_eln4Wwdyqw8niA97w7bpv6&index=6
TAPE 1 - REVELATION RUMBLINGS
DANIEL VERSE BY VERSE BY DR JACK AND REXELLA VAN IMPE
https://www.youtube.com/watch?v=5zvrylU6E2A
TAPE 1 - DAN 1:1 TO DAN 3:30
https://www.youtube.com/watch?v=dySOniNlbjA
TAPE 2 - DAN 4:1 TO DAN 6:28
https://www.youtube.com/watch?v=zPlfIHcQVrE
TAPE 3 - DAN 7:1 TO DAN 9:27
https://www.youtube.com/watch?v=CHB_jtS6NF8
TAPE 4 - DAN 10:1 TO DAN 12:13
ISLAM I BELIEVE IS A MADE UP FAKE CHRISTIAN RELGION IMMITATION.DREAMPT UP IN 600BC. (WATCH 2ND)
https://www.youtube.com/watch?v=4EaopH_EPfc
ARABS-NAME AN IMPORTANT ARAB IN HISTORY (WATCH 1ST)
https://www.youtube.com/watch?v=deiShtWReYE
GAYS MARRYING-EVERYBODY CAN JOIN THE CATHOLIC CHURCH.
https://www.cbsnews.com/video/pope-francis-opens-meeting-on-future-of-catholic-church-by-saying-everyone-must-be-allowed-in/
https://duckduckgo.com/?q=POPE+FRANCIS+ANYBODY+CAN+JOIN+THE+CATHOLIC+CURCH+VIDEO&t=newext&atb=v387-1&iax=videos&ia=videos&iai=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DMKh2nNVjV24
JVI THE FINAL POPE
https://www.youtube.com/watch?v=QIY8wdebNqo
A NEW VEXAS SYNDROME FROM KILLER COVID VACCINE SHOTS.
DISEASES-ANIMAL TO HUMAN ( 500 million Dead )
REVELATION 6:7-8
7 And when he had opened the fourth seal, I heard the voice of the fourth beast say, Come and see.
8 And I looked, and behold a pale horse:(CHLORES GREEN) and his name that sat on him was Death, and Hell followed with him. And power was given unto them over the fourth part of the earth,(2 billion) of (8 billion) to kill with sword,(WEAPONS)(500 million) and with hunger,(FAMINE)(500 million) and with death,(INCURABLE DISEASES)(500 million) and with the beasts of the earth.(ANIMAL TO HUMAN DISEASE)(500 million).
DRUG PUSHERS AND ADDICTS
1 PET 5:8
8 Be sober,(NOT DRUGED UP OR ALCOHOLICED) be vigilant; because your adversary the devil, as a roaring lion, walketh about, seeking whom he may devour:
REVELATION 18:23
23 And the light of a candle shall shine no more at all in thee; and the voice of the bridegroom and of the bride shall be heard no more at all in thee: for thy merchants were the great men of the earth; for by thy sorceries (DRUGS) were all nations deceived.
REVELATION 9:21 (RAGE OF THE LAST DAYS AGE SATAN WORSHIP AND DRUG SELLING AND JUNKIES)(THEY REFUSE TO REPENT OF THESE SINS)
21 Neither repented they of their murders,(KILLING) nor of their sorceries (DRUG ADDICTS AND DRUG PUSHERS), nor of their fornication,(SEX OUTSIDE MARRIAGE OR PROSTITUTION FOR MONEY) nor of their thefts.(STEALING)
COLORADO IS GETTING JUDGEMENT ON THEM AS A RESULT OF TRYING TO GET TRUMP BANNED FROM THE VOTING BALLOT.THE NURSES AND WORKERS IN COLORADO ARE ALL GETTING LIVE EBOLA VACCINE SHOTS. THAT SHED TO OTHER PEOPLE. DISQUISED AS THE COVID SHOT.
BREAKING: Americans Being Infected With Live Ebola By Secret Bill Gates Project-The Alex Jones Show | Infowars.com-January 19th 2024, 1:38 pm
https://www.infowars.com/posts/breaking-americans-being-infected-with-live-ebola-by-secret-bill-gates-project/
Watch: Rep. MTG Holds Hearing on ‘Blood-Related’ Injuries Caused by Covid-19 Vaccines-Infowars.com-January 18th 2024, 2:17 pm
Dr. Peter McCullough lays out how American food supply could be in danger after USDA allowed pork injected with DNA and RNA vaccines.
Congresswoman Marjorie Taylor Greene (R-Ga.) held a hearing last week where top doctors laid out evidence exposing how Covid-19 jabs have caused severe “blood-related injuries” in some recipients.Dr. Peter McCullough, Dr. Ryan Cole, and Dr. Kirk Milhoan delivered testimony at Rep. Greene’s second hearing on the matter, expressing how doctors were injecting healthy patients with jabs for financial benefit while ignoring safety data. Big Pharma was offering huge bonuses to doctors who would carelessly inject their patients with the experimental COVID-19 vaccines. At the same time, doctors wanting to exempt a totally healthy patient from the experimental vaccines were supposed to IGNORE the safety data. pic.twitter.com/8oJuOHhtaz-— Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) January 17, 2024-Dr. McCullough also laid out how the American food supply could be in dan after the USDA allowed pork to be sold that has been injected with DNA and RNA vaccines, which could potentially then be transferred to consumers.The federal government should not be playing God.The USDA has been allowing self replicating RNA and DNA to be injected into the American pork supply as a part of a genetic project.The American people are not lab rats!@P_McCulloughMD pic.twitter.com/4C5aYJVJsS- Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) January 18, 2024-Watch the full hearing below:
https://www.infowars.com/posts/watch-rep-mtg-holds-hearing-on-blood-related-injuries-caused-by-covid-19-vaccines/
Spin-off DISEASE: Fully Vaccinated for COVID Manifesting New Disease Called VEXAS Syndrome-by Ethan Huff | NaturalNews.com-January 19th 2024, 3:35 am-Autoinflammatory ailment was first discovered in 2020 around the time Operation Warp Speed was launched.
People who were injected with “vaccines” for the Wuhan coronavirus (COVID-19) are increasingly being diagnosed with a new type of disease they are calling VEXAS syndrome, an autoinflammatory ailment that was first discovered in 2020 around the time Operation Warp Speed was launched by the Trump regime.VEXAS syndrome, short for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome, is said to be caused by mutations in the innate immune cells, as well as a somatic mutation in the UBA1 gene found on the X chromosome. Most inflammatory diseases, by the way, are caused by dysfunction that arises in adaptive immune cells.“Somatic mutations cannot be inherited, meaning individuals acquire this mutation later in life,” explains The Epoch Times about the disease. “The mutation affects the stem cells in the bone marrow. The cells mature into specialized immune cells that circulate within the bloodstream.”“Immune cells carrying the UBA1 mutation are highly inflammatory, and once enough of them accumulate, patients start developing symptoms.” Introducing Next Level Foundational Energy from Dr. Jones Naturals starting at 30% off! This cutting-edge dietary supplement is designed to elevate your energy levels and support your overall well-being.Autoinflammation caused by COVID jabs-Back in April, French scientists reported on the case of a 76-year-old man who almost immediately after getting jabbed for COVID with Pfizer’s mRNA (modRNA) variety was diagnosed with VEXAS syndrome. His symptoms included tender bumps under the skin, rashes and purple spots on his limbs.Skin problems are commonly reported among VEXAS patients, and the man was no exception. He was later determined by specialists to have the UBA1 mutation inherent to the disease.“The rare incidence of VEXAS syndrome and the short delay of 3 days between vaccination and onset of symptoms were very suggestive of the vaccine’s role as a trigger,” the study authors, from Drôme Nord Hospitals, wrote.Another patient, 72, developed similar symptoms, as well as a fever, fatigue, a cough and deep vein thrombosis. He was initially misdiagnosed with “long COVID,” only to later also show evidence of the same UBA1 mutation as the first patient.“In my experience, it is unlikely that VEXAS syndrome could have been triggered by an infection or COVID-19 vaccination,” commented Dr. Sinisa Savic, an immunologist and associate clinical professor at the University of Leeds. “We know that as people age, they develop all sorts of mutations in the bone marrow … That is why VEXAS is largely found in the elderly population.”Typically, VEXAS syndrome occurs in men over the age of 50. Both infections and vaccinations can trigger or worsen symptoms in people who are already on track to develop VEXAS syndrome.“Anything that triggers an immune response can cause temporary worsening symptoms,” Dr. Savic added. “I don’t think there’s any particular argument about that.”Among specialized immune cells, only innate immune cells have been found to carry the UBA1 mutation. Adaptive immune cells, meanwhile, form what is known as the “third” or last line of defense against disease, and these cells have not been found to carry the UBA1 mutation.Dr. Savic believes that adaptive immune cells, including T and B cells, probably cannot survive long enough to become specialized if they carry the UBA1 mutation. Specialization of innate immune cells, conversely, appear to be less affected by the UBA1 mutation.Both infections and vaccinations trigger responses in the immune system that are supposed to (in theory for vaccinations, anyway) form immune memory. This process does not occur in people with autoinflammatory conditions – in fact, an immune reaction can cause an imbalance that actually worsens a patient’s condition.“This is the case with any autoimmune or inflammatory condition because the immune system tries to control itself, but if you’re then challenged by something else, then that level of control may be reduced,” Dr. Savic said.More related news can be found at VaccineInjuryNews.com.
Musk Shocked Insurance Company Bribed Health Providers To Push Covid Shots-by Kelen McBreen-January 19th 2024, 2:06 pm
Kentucky GOP Rep. Thomas Massie posted a screenshot to 𝕏 Friday exposing Anthem Blue Cross and Blue Shield’s scheme to provide financial incentives to healthcare providers for administering Covid shots.𝕏 owner Elon Musk responded to the post with “!!” to express his shock about the disturbing news.“Your primary care provider was bribed to get you to take the jab. ‘Oh, but Congressman Massie, these were incentive payments, not bribes.’ As always, follow the money,” Massie wrote, along with a document showing the insurance company was paying doctors to push the jabs.!!— Elon Musk (@elonmusk) January 19, 2024-The Anthem Blue Cross and Blue Shield document explains, “The COVID-19 Vaccine Provider Incentive program is open” to qualifying Kentucky healthcare providers. Introducing Next Level Foundational Energy from Dr. Jones Naturals starting at 30% off! This cutting-edge dietary supplement is designed to elevate your energy levels and support your overall well-being.Under a section titled, “How you can qualify for a bonus,” the paper told health practitioners they’d receive payments for meeting certain thresholds provided by the insurance giant.For example, doctors who were able to get 75% or more of their patients to take the experimental Covid shots before September 1, 2021, received $125 per person they jabbed.According to the American Association for Physician Leadership, a primary care provider could care for up to 3,000 patients, but the ideal average is estimated at 1,000.If a doctor reached the 75% threshold and had 1,000 patients, they’d get a $93,750 bonus.Between September 1 and December 31, 2021, doctors who reached the 75% threshold received $250 per vaccination.That means practitioners with 1,000 patients would have been paid a $187,500 bonus in a four-month period.The establishment has been trying to hide the fact doctors were paid to push the shots because it is a massive red flag, and would promote even more vaccine hesitancy and distrust in medical professionals.In a 2022 article “fact-checking” the claim that “Blue Cross Blue Shield pays doctors bonuses based on the number of patients vaccinated,” USA Today played word games with their readers by claiming the insurance company “doesn’t provide incentives solely based on the number of patients vaccinated.”However, as the Kentucky congressman’s post showed, doctors were being provided incentives specifically focused on the COVID-19 shots.The American people deserve to know how widespread incentive schemes were and if they’re still in operation.
WHO admits 'we are not prepared' for next pandemic as Disease X could kill 50 million-The world isn't ready for a potential future pandemic caused by the yet unknown Disease X, a health expert warned at the World Economic Forum in Davos, Switzerland.By Charlie Bradley-12:42, Wed, Jan 17, 2024 |
The world is "still not prepared" for the next pandemic, the Director-General of the World Health Organization (WHO) warned - experts believe the next outbreak could be even worse than COVID-19.Tedros Adhanom Ghebreyesus made the stark warning while appearing at the World Economic Forum (WEF) in Davos, Switzerland. He and other experts spoke on a panel titled Preparing for Disease X.Disease X is a placeholder name for an unknown virus that could infect humans in the future that experts believe could kill as many as 50 million people.Shyam Bishen, Head of the Centre for Health and Healthcare at the WEF, opened the event by saying: "How do we prepare for the next emergency?"How do we prepare our health system overall for the next pandemic? We all know very well there will be viruses, there will be pathogens, there will be outbreaks. The idea is how do we prepare to contain those? How do we prevent outbreaks from becoming full-blown pandemics?"During the event, Mr Ghebreyesus urged leaders around the world to back the WHO Pandemic Preparedness Treaty – launched in 2021 to try and reach international consensus on how to deal with the next pandemic.Mr Ghebreyesus said: "[The] key to being better prepared and to address Disease X is the pandemic agreement. It can bring all the experience, all the challenges we faced and all the solutions into one. This is about a common enemy. Without a shared response we will face the same problems we saw with Covid."He added: "If our generation cannot do it, with the firsthand experience, I don't think the next generation will do it."We are still not prepared, but I think there are many moving parts and we have started good ones, all of us together, that can prepare us better."The authors of the WHO Pandemic Preparedness Treaty said in a joint statement: "The main goal of this treaty would be to foster an all-of-government and all-of-society approach, strengthening national, regional and global capacities and resilience to future pandemics."This includes greatly enhancing international co-operation to improve, for example, alert systems, data-sharing, research and local, regional and global production and distribution of medical and public health counter-measures such as vaccines, medicines, diagnostics and personal protective equipment."The treaty will be subject to amendments from various leaders around the world. The deadline for the treaty is May 2024, however, differences of opinion between countries mean that the treaty may not pass at all.Kate Bingham, who served as the chair of the UK's Vaccine Taskforce, was asked by the Daily Mail how many people could die as a result of Disease X.She replied: "Let me put it this way: the 1918-19 flu pandemic killed at least 50 million people worldwide, twice as many as were killed in World War I. Today, we could expect a similar death toll from one of the many viruses that already exist."
FDA News Release-First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response-For Immediate Release:December 19, 2019
The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. Cases of EVD are very rare in the U.S., and those that have occurred have been the result of infections acquired by individuals in other countries who then traveled to the U.S., or health care workers who became ill after treating patients with EVD.“While the risk of Ebola virus disease in the U.S. remains low, the U.S. government remains deeply committed to fighting devastating Ebola outbreaks in Africa, including the current outbreak in the Democratic Republic of the Congo,” said Anna Abram, FDA Deputy Commissioner for Policy, Legislation, and International Affairs. “Today’s approval is an important step in our continuing efforts to fight Ebola in close coordination with our partners across the U.S. Department of Health and Human Services, as well as our international partners, such as the World Health Organization. These efforts, including today’s landmark approval, reflect the FDA’s unwavering dedication to leveraging our expertise to facilitate the development and availability of safe and effective medical products to address urgent public health needs and fight infectious diseases, as part of our vital public health mission.”EVD is contagious and is transmitted through direct contact with blood, body fluids and tissues of infected wild animals or people, as well as with surfaces and materials, such as bedding and clothing, contaminated with these fluids. Onset of symptoms of EVD can be sudden and can include fever, fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, impaired kidney and liver function and in some cases internal and external bleeding. EVD has an incubation period that ranges from 2 to 21 days. Individuals who provide care for people with EVD, including health care workers who do not use correct infection control precautions, are at the highest risk for infection.Confirmed outbreaks of EVD have been documented since the 1970s, primarily in areas of sub-Saharan Africa, where scientists believe the virus is always present at low levels in certain infected wild animals. On rare occasions, people become sick with EVD after coming into direct contact with infected animals, which can then lead to EVD outbreaks when the virus spreads between people.An outbreak in three West African countries (Guinea, Liberia and Sierra Leone) from 2014 to 2016 resulted in more than 28,000 cases of EVD and more than 11,000 deaths that were caused by Zaire ebolavirus.The Democratic Republic of the Congo (DRC) is currently experiencing the world’s second largest EVD outbreak. In 2018, the World Health Organization (WHO) and the DRC began to use Ervebo as an investigational vaccine under an expanded access program to help mitigate this outbreak. With or without vaccination, it is critical to implement appropriate infection control and prevention measures as part of efforts to prevent the spread of EVD.“Ebola virus disease is a rare but severe and often deadly disease that knows no borders. Vaccination is essential to help prevent outbreaks and to stop the Ebola virus from spreading when outbreaks do occur,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “The FDA’s approval of Ervebo is a major advance in helping to protect against the Zaire ebolavirus as well as advancing U.S. government preparedness efforts. The research approach used to study the effectiveness and safety of this vaccine was precedent-setting during a public health emergency and may help create a model for future studies under similar circumstances. The FDA is committed to continuing our work across the U.S. government and with our international partners to prevent future Ebola outbreaks and mitigate the current outbreak in the DRC, reflecting our nation’s commitment to preparing for and responding to biological threats, like Ebola.”The approval of Ervebo is supported by a study conducted in Guinea during the 2014-2016 outbreak in individuals 18 years of age and older. The study was a randomized cluster (ring) vaccination study in which 3,537 contacts and contacts of contacts of individuals with laboratory-confirmed EVD received either “immediate” or 21-day “delayed” vaccination with Ervebo. This noteworthy design was intended to capture a social network of individuals and locations that might include dwellings or workplaces where a patient spent time while symptomatic, or the households of individuals who had contact with the patient during that person’s illness or death. In a comparison of cases of EVD among 2,108 individuals in the “immediate” vaccination arm and 1,429 individuals in the “delayed” vaccination arm, Ervebo was determined to be 100% effective in preventing Ebola cases with symptom onset greater than 10 days after vaccination. No cases of EVD with symptom onset greater than 10 days after vaccination were observed in the “immediate” cluster group, compared with 10 cases of EVD in the 21-day “delayed” cluster group.In additional studies, antibody responses to Ervebo were assessed in 477 individuals in Liberia, approximately 500 individuals in Sierra Leone and approximately 900 individuals in Canada, Spain and the U.S. The antibody responses among those in the study conducted in Canada, Spain and the U.S. were similar to those among individuals in the studies conducted in Liberia and Sierra Leone. The safety of Ervebo was assessed in approximately 15,000 individuals in Africa, Europe and North America. The most commonly reported side effects were pain, swelling and redness at the injection site, as well as headache, fever, joint and muscle aches and fatigue.Ervebo is administered as a single-dose injection, and is a live, attenuated vaccine that has been genetically engineered to contain a protein from the Zaire ebolavirus.The FDA granted this application Priority Review and a Tropical Disease Priority Review Voucher under a program intended to encourage development of new drugs and biologics for the prevention and treatment of certain tropical diseases. The FDA also granted Breakthrough Therapy designation for Ervebo to facilitate the development and scientific evaluation of the vaccine. Because of the public health importance of a vaccine to prevent EVD, the FDA worked closely with the company and completed its evaluation of the safety and effectiveness of Ervebo in less than six months.The approval was granted to Merck & Co., Inc.The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
TREATMENT OF EBOLA
Supportive care - rehydration with oral or intravenous fluids - and treatment of specific symptoms improves survival. A range of potential treatments including blood products, immune therapies and drug therapies are currently being evaluated. In the 2018-2020 Ebola outbreak in DRC, the first-ever multi-drug randomized control trial was conducted to evaluate the effectiveness and safety of drugs used in the treatment of Ebola patients under an ethical framework developed in consultation with experts in the field and the DRC.Two monoclonal antibodies (Inmazeb and Ebanga) were approved for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children by the US Food and Drug Administration in late 2020. The Ervebo vaccine has been shown to be effective in protecting people from the species Zaire ebolavirus, and is recommended by the Strategic Advisory Group of Experts on Immunization as part of a broader set of Ebola outbreak response tools. In December 2020, the vaccine was approved by the US Food and Drug Administration and prequalified by WHO for use in individuals 18 years of age and older (except for pregnant and breastfeeding women) for protection against Ebola virus disease caused by Zaïre Ebola virus. In May 2020, the European Medicines Agency recommended granting marketing authorization for a 2-component vaccine called Zabdeno-and-Mvabea for individuals 1 year and older. The vaccine is delivered in 2 doses: Zabdeno is administered first and Mvabea is given approximately 8 weeks later as a second dose. This prophylactic 2-dose regimen is therefore not suitable for an outbreak response where immediate protection is necessary.
